Dr. Hui Cai has been appointed as vice president of business development, WuXi PharmaTech. Dr. Cai will report directly to Dr. Richard Soll, senior vice president of Integrated Services.

Prior to joining the company, Dr. Cai was president of Inflexion BioPartners and vice president of corporate development at HUYA Bioscience. Previously, Dr. Cai spent ten years at Johnson & Johnson Pharmaceutical R&D on multiple small molecule drug discovery programs.

"I am very pleased to welcome Hui on board as we continue to enhance our business development," commented Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech. "Hui brings us a broad portfolio of expertise and experience in strategic planning, business development, and portfolio management, with which we are confident that our discovery business will grow rapidly."

News from our sister sites